The management of anemia in the myelodysplastic syndrome

Leukemia Research

Volumn 29, Issue 10, 2005, Pages 1101-1102

  Hamblin, Terry J ^a  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; BLOOD TRANSFUSION; DISEASE COURSE; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEART FAILURE; HUMAN; INFECTION RISK; IRON CHELATION; MEDICAL RESEARCH; MITRAL VALVE REGURGITATION; MYELODYSPLASTIC SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION;

EID: 23844490445     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.03.009     Document Type: Editorial

References (6)

1. D. Bowen, D. Culligan, and S. Jowitt Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes Br J Haematol 120 2003 187 200
2. E. Terpos, A. Mougiou, and A. Kouraklis Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients Br J Haematol 118 2002 174 180
3. E. Hellstrom-Lindberg, N. Gulbrandsen, and G. Lindberg A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life Br J Haematol 120 2003 1037 1046
4. P. Musto, F. Lanza, and E. Balleari Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes Br J Haematol 128 2005 204 209
5. A.F. List, J. Vardiman, and J.-P.J. Issa Myelodysplastic syndromes Hematology (Amer Soc Hematol Educ Program) 2004 297 315
6. E.N. Oliva, B.D. Dimitrov, F. Benedetto, A. D'Angelo, and F. Nobile Hemoglobin level threshold for cardiac remodeling and quality of life Leuk Res 29 2005 1217 1219